Compare VISTA PHARMA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA ADVANCED ENZYME TECHNOLOGIES VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x -15.8 24.6 - View Chart
P/BV x 1.5 3.8 39.4% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 VISTA PHARMA   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    VISTA PHARMA
Mar-21
ADVANCED ENZYME TECHNOLOGIES
Mar-21
VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs16417 3.9%   
Low Rs5129 3.7%   
Sales per share (Unadj.) Rs0.344.9 0.8%  
Earnings per share (Unadj.) Rs-0.513.6 -3.8%  
Cash flow per share (Unadj.) Rs-0.316.1 -2.0%  
Dividends per share (Unadj.) Rs00.60 0.0%  
Avg Dividend yield %00.2 0.0%  
Book value per share (Unadj.) Rs8.986.6 10.3%  
Shares outstanding (eoy) m36.79111.73 32.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x30.36.1 499.4%   
Avg P/E ratio x-20.420.1 -101.3%  
P/CF ratio (eoy) x-33.217.0 -195.9%  
Price / Book Value ratio x1.23.1 37.1%  
Dividend payout %04.4 0.0%   
Avg Mkt Cap Rs m38430,491 1.3%   
No. of employees `000NANA-   
Total wages/salary Rs m12871 1.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m135,018 0.3%  
Other income Rs m388 3.6%   
Total revenues Rs m165,107 0.3%   
Gross profit Rs m-172,325 -0.7%  
Depreciation Rs m7284 2.6%   
Interest Rs m1526 60.6%   
Profit before tax Rs m-372,104 -1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-18589 -3.1%   
Profit after tax Rs m-191,515 -1.2%  
Gross profit margin %-136.646.3 -294.9%  
Effective tax rate %48.928.0 174.6%   
Net profit margin %-148.930.2 -493.4%  
BALANCE SHEET DATA
Current assets Rs m1525,161 3.0%   
Current liabilities Rs m92676 13.7%   
Net working cap to sales %473.289.4 529.5%  
Current ratio x1.67.6 21.6%  
Inventory Days Days2,409102 2,367.9%  
Debtors Days Days6,25463 9,966.7%  
Net fixed assets Rs m3746,297 5.9%   
Share capital Rs m74223 32.9%   
"Free" reserves Rs m2559,457 2.7%   
Net worth Rs m3289,680 3.4%   
Long term debt Rs m8799 88.1%   
Total assets Rs m52611,458 4.6%  
Interest coverage x-1.483.3 -1.7%   
Debt to equity ratio x0.30 2,595.6%  
Sales to assets ratio x00.4 5.5%   
Return on assets %-0.613.4 -4.8%  
Return on equity %-5.715.6 -36.7%  
Return on capital %-5.121.8 -23.6%  
Exports to sales %012.9 0.0%   
Imports to sales %05.9 0.0%   
Exports (fob) Rs mNA648 0.0%   
Imports (cif) Rs mNA298 0.0%   
Fx inflow Rs m1648 0.2%   
Fx outflow Rs m0298 0.0%   
Net fx Rs m1351 0.3%   
CASH FLOW
From Operations Rs m-671,629 -4.1%  
From Investments Rs m-3-260 1.1%  
From Financial Activity Rs m70-263 -26.5%  
Net Cashflow Rs m-11,093 -0.1%  

Share Holding

Indian Promoters % 2.0 12.2 16.8%  
Foreign collaborators % 34.9 40.6 86.0%  
Indian inst/Mut Fund % 0.2 25.4 0.6%  
FIIs % 0.1 16.4 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 63.1 47.3 133.3%  
Shareholders   13,004 84,346 15.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

ADVANCED ENZYME TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of ADVANCED ENZYME TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ADVANCED ENZYME TECHNOLOGIES. Also includes updates on the valuation of ADVANCED ENZYME TECHNOLOGIES.

ADVANCED ENZYME TECHNOLOGIES Announces Quarterly Results (1QFY22); Net Profit Up 14.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ADVANCED ENZYME TECHNOLOGIES has posted a net profit of Rs 399 m (up 14.5% YoY). Sales on the other hand came in at Rs 1 bn (up 24.0% YoY). Read on for a complete analysis of ADVANCED ENZYME TECHNOLOGIES's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VISTA PHARMA SHARE PRICE


Jan 20, 2022 (Close)

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

VISTA PHARMA 8-QTR ANALYSIS

COMPARE VISTA PHARMA WITH

MARKET STATS